|
|
Dato for indtastning
|
4862 |
Erwinase, 10,000 IU/vial, Powder for solution for injection/infusion - Summary of Product Characteristics Updated 04-Jul-2022. Porton Biopharma Limited |
04/09/2024 |
4843 |
Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration. Pharmaceutics |
30/06/2024 |
4842 |
Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors Drug Design Dev Ther |
28/06/2024 |
4828 |
The Physical Compatibility of Glycopyrrolate and Rocuronium. Anesth Prog |
15/06/2024 |
4831 |
Frequently acquired drugs in neonatal intensive care and their physical compatibility. Acta Paediatr |
15/06/2024 |
4832 |
Co‑administration of drugs with parenteral nutrition in the neonatal intensive care unit—physical compatibility between three components. Eur J Pedia |
15/06/2024 |
4824 |
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials. EJHP |
03/06/2024 |
4825 |
Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops. Farm Hosp |
03/06/2024 |
4822 |
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC Antimicrob Resist |
08/05/2024 |
4821 |
AmBisome® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies. Pharmaceutics |
28/04/2024 |
4820 |
Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags. EJHP |
17/04/2024 |
4819 |
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations. Int J Pharm |
09/04/2024 |
4818 |
Giapreza 2.5mg per ml concentrate for solution for infusion - Summary of Product Characteristics Updated 30-Jun-2022 PAION UK Ltd |
04/04/2024 |
4816 |
Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro Cream Base, Versa Pro Gel Base and PLO Gel Mediflo30 Compound Kit. Int J Pharm Compound |
26/03/2024 |
4813 |
Compatibility of Various Hormones in Phytobase and HRT Heavy Cream Bases Int J Pharm Compound |
25/03/2024 |
4814 |
Compatiblity of Caffeine, Clobetasol Propionate, Dutasteride, Nicotinamide, and Progesterone in TrichoFoam, a Natural Vehicle for Hair Forms. Int J Pharm Compound |
25/03/2024 |
4812 |
Stability of extemporaneously prepared clofazimine oral suspensions J Pharm Pract and Res |
20/03/2024 |
4808 |
Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry. Hosp Pharm |
06/03/2024 |
4807 |
Vectibix 20 mg/mL concentrate for solution for infusion. Summary of Product Characteristics Updated 13-Jul-2023 Amgen Ltd |
21/02/2024 |
4801 |
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm |
18/01/2024 |
4802 |
Glucose-1-Phosphate disodique tétrahydraté (Phocytan®) - Résumé des caractéristiques du produit Aguettant Laboratory |
18/01/2024 |
4798 |
A silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology |
12/01/2024 |
4799 |
Stability of Voriconazole 10 mg/mL in IsoptoTears 0.5% stored in Glass Vials And Low Density Polyethylene Droppers at 4°C and 25°C for 28 Days. |
12/01/2024 |
4800 |
Stability of Dr.Reddy’s Cabazitaxel Following Reconstitution with Manufacturer’s Diluent & Dilution with Sodium Chloride and Dextrose 5% in non-PVC non-DEHP bags and Original Glass Vials at 25°C, 4°C and -20°C.
|
12/01/2024 |
4792 |
Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy. EJHP |
15/12/2023 |
4789 |
Stability of sulfadiazine sugar-free oral suspensions for the treatment of congenital toxoplasmosis. Braz J Pharm Sci |
15/11/2023 |
4790 |
Pharmaceutical compounding and storage of faricimab in a syringe for intravitreal injection do not impair stability and bi-specific binding properties. Int J Retina Vitreous |
15/11/2023 |
4786 |
Etude de stabilité de solutions de pembrolizumab à 1 et 4 mg/mL à 5 et 25°C dans des poches de NaCl 0,9% en polyoléfine . SFPO Congress |
07/11/2023 |
4784 |
In-use stability of ready-to- administer daratumumab subcutaneous injection solution in plastic syringes. EJHP |
04/11/2023 |
4785 |
Darzalex 1800 mg solution for injection - Summary of Product characteristics. Janssen-Cilag International NV |
04/11/2023 |